Adam Adam
-
Read more: The Legal Status of Ritalin in the UKRitalin, the brand name for methylphenidate, is a central nervous system stimulant widely recognized for its role in managing attention deficit hyperactivity disorder (ADHD) and,…
-
Read more: The Legal Status of Atomoxetine in Switzerland: An In-Depth OverviewAtomoxetine, commonly known by its brand name Strattera, is a non-stimulant medication primarily prescribed for attention deficit hyperactivity disorder (ADHD). As a selective norepinephrine reuptake…
-
Read more: Legality of Solriamfetol in the USA: A Comprehensive ExaminationSolriamfetol in the USA is marketed under the brand name Sunosi, represents a significant advancement in treating excessive daytime sleepiness associated with sleep disorders. As…
-
Read more: The Legal Status of Vyvanse in Australia
Vyvanse, the brand name for lisdexamfetamine dimesylate, is a central nervous system stimulant widely used to manage attention deficit hyperactivity disorder (ADHD). As a prodrug…
-
Read more: Legal Status of Atomoxetine in the United States and Its AlternativesAtomoxetine in the USA, best known under the brand name Strattera, has become a widely recognized non-stimulant option for managing attention-deficit/hyperactivity disorder (ADHD) in the…
-
Read more: Legal Status of Pitolisant in AustraliaAs of today, pitolisant (commonly marketed under names such as Wakix) is not approved for medical use in Australia. While it has secured regulatory approval…
-
Read more: Adderall in Singapore: Legal Status OverviewAdderall is a prescription medication composed of mixed amphetamine salts, commonly used to treat ADHD (attention-deficit/hyperactivity disorder) and narcolepsy. It falls under the stimulant class…
-
Read more: Legal Status of Solriamfetol in AustraliaSolriamfetol, marketed under the brand name Sunosi, is a newer wakefulness-promoting medication approved in the United States and European Union for excessive daytime sleepiness (EDS)…
-
Read more: Zolpidem in Australia: Legal Status Overview1. Regulatory Classification In Australia, zolpidem is classified as a Schedule 4 (S4) substance under the Poisons Standard (SUSMP). Schedule 4 comprises prescription-only medications that…
-
Read more: Legal status of zopiclone in SwitzerlandZopiclone is a non‑benzodiazepine “Z‑drug” used for the short‑term treatment of insomnia. Despite its chemical difference from benzodiazepines, it acts similarly via GABAA and carries…